25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Merck & Company Inc
Buy, Hold or Sell?

Let's analyze Merck & Company Inc together

I guess you are interested in Merck & Company Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Merck & Company Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Merck & Company Inc

I send you an email if I find something interesting about Merck & Company Inc.

1. Quick Overview

1.1. Quick analysis of Merck & Company Inc (30 sec.)










1.2. What can you expect buying and holding a share of Merck & Company Inc? (30 sec.)

How much money do you get?

How much money do you get?
€2.90
When do you have the money?
1 year
How often do you get paid?
63.2%

What is your share worth?

Current worth
€65.82
Expected worth in 1 year
€70.06
How sure are you?
73.7%

+ What do you gain per year?

Total Gains per Share
€7.01
Return On Investment
5.1%

For what price can you sell your share?

Current Price per Share
€138.30
Expected price per share
€133.83 - €143.09
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Merck & Company Inc (5 min.)




Live pricePrice per Share (EOD)
€138.30
Intrinsic Value Per Share
€27.88 - €31.33
Total Value Per Share
€93.70 - €97.15

2.2. Growth of Merck & Company Inc (5 min.)




Is Merck & Company Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$29.9b$28.1b$1.1b3.9%

How much money is Merck & Company Inc making?

Current yearPrevious yearGrowGrow %
Making money$687.9m$806.3m-$118.4m-17.2%
Net Profit Margin12.6%13.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Merck & Company Inc (5 min.)




2.4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#17 / 338

Most Revenue
#34 / 338

Most Profit
#23 / 338
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Merck & Company Inc?

Welcome investor! Merck & Company Inc's management wants to use your money to grow the business. In return you get a share of Merck & Company Inc.

First you should know what it really means to hold a share of Merck & Company Inc. And how you can make/lose money.

Speculation

The Price per Share of Merck & Company Inc is €138.30. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Merck & Company Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Merck & Company Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €65.82. Based on the TTM, the Book Value Change Per Share is €1.06 per quarter. Based on the YOY, the Book Value Change Per Share is €0.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.69 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Merck & Company Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps1.461.1%1.581.1%1.851.3%1.541.1%1.401.0%
Usd Book Value Change Per Share1.310.9%1.110.8%0.450.3%3.632.6%3.632.6%
Usd Dividend Per Share0.680.5%0.730.5%0.660.5%0.520.4%0.520.4%
Usd Total Gains Per Share1.991.4%1.841.3%1.100.8%4.153.0%4.153.0%
Usd Price Per Share162.42-162.16-176.03-159.14-153.88-
Price to Earnings Ratio27.76-25.77-24.17-24.75-22.50-
Price-to-Total Gains Ratio81.59-21.23-74.96--55.62--55.62-
Price to Book Ratio2.35-2.41-2.73-2.81-2.56-
Price-to-Total Gains Ratio81.59-21.23-74.96--55.62--55.62-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share144.92457
Number of shares6
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.730.52
Usd Book Value Change Per Share1.113.63
Usd Total Gains Per Share1.844.15
Gains per Quarter (6 shares)11.0224.92
Gains per Year (6 shares)44.0899.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1172734138790
235537825174190
3528012238261290
47010716650348390
58713321063436490
610416025475523590
712218729888610690
8139213342100697790
9157240386113784890
10174267430125871990

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%14.05.00.073.7%14.05.00.073.7%14.05.00.073.7%
Dividend per Share3.00.01.075.0%8.00.04.066.7%12.00.07.063.2%12.00.07.063.2%12.00.07.063.2%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%14.05.00.073.7%14.05.00.073.7%14.05.00.073.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Merck & Company Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.2471.060+18%0.427+192%3.464-64%3.464-64%
Book Value Per Share--65.81864.251+2%61.723+7%50.381+31%45.801+44%
Current Ratio--1.3141.398-6%1.371-4%1.185+11%1.170+12%
Debt To Asset Ratio--0.4260.435-2%0.455-6%0.511-17%0.514-17%
Debt To Equity Ratio--0.7450.773-4%0.837-11%1.080-31%1.093-32%
Dividend Per Share--0.6530.692-6%0.627+4%0.499+31%0.499+31%
Eps--1.3961.510-8%1.770-21%1.473-5%1.339+4%
Free Cash Flow Per Share--1.1731.171+0%1.182-1%1.264-7%1.264-7%
Free Cash Flow To Equity Per Share--1.1731.171+0%1.182-1%1.264-7%1.264-7%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--31.331--------
Intrinsic Value_10Y_min--27.880--------
Intrinsic Value_1Y_max--4.860--------
Intrinsic Value_1Y_min--4.775--------
Intrinsic Value_3Y_max--13.292--------
Intrinsic Value_3Y_min--12.716--------
Intrinsic Value_5Y_max--20.143--------
Intrinsic Value_5Y_min--18.809--------
Market Cap--67390571090.00067281876504.500+0%73037139918.068-8%63776892932.254+6%57978993574.777+16%
Net Profit Margin--0.1130.126-10%0.139-19%0.131-13%0.127-10%
Operating Margin----0%-0%0.083-100%0.098-100%
Operating Ratio--1.2481.260-1%1.188+5%1.215+3%1.217+3%
Pb Ratio2.101-12%2.3552.408-2%2.727-14%2.811-16%2.556-8%
Pe Ratio24.765-12%27.75625.774+8%24.166+15%24.747+12%22.497+23%
Price Per Share138.300-12%155.000154.750+0%167.987-8%151.866+2%146.843+6%
Price To Free Cash Flow Ratio29.475-12%33.03538.784-15%51.541-36%36.816-10%33.469-1%
Price To Total Gains Ratio72.796-12%81.58721.226+284%74.956+9%-55.621+168%-55.621+168%
Quick Ratio--0.4420.476-7%0.518-15%0.425+4%0.417+6%
Return On Assets--0.0120.013-8%0.016-22%0.014-14%0.014-11%
Return On Equity--0.0210.024-10%0.029-26%0.029-27%0.028-24%
Total Gains Per Share--1.9001.753+8%1.054+80%3.963-52%3.963-52%
Usd Book Value--29986706400.00029273086500.000+2%28121444400.000+7%23906528625.000+25%23412181800.000+28%
Usd Book Value Change Per Share--1.3061.111+18%0.448+192%3.630-64%3.630-64%
Usd Book Value Per Share--68.97067.329+2%64.680+7%52.795+31%47.995+44%
Usd Dividend Per Share--0.6840.725-6%0.657+4%0.523+31%0.523+31%
Usd Eps--1.4631.582-8%1.855-21%1.544-5%1.404+4%
Usd Free Cash Flow--534429000.000533643075.000+0%538358625.000-1%584256645.000-9%567818904.545-6%
Usd Free Cash Flow Per Share--1.2291.227+0%1.238-1%1.325-7%1.325-7%
Usd Free Cash Flow To Equity Per Share--1.2291.227+0%1.238-1%1.325-7%1.325-7%
Usd Market Cap--70618579445.21170504678389.066+0%76535618920.144-8%66831806103.709+6%60756187367.008+16%
Usd Price Per Share144.925-12%162.425162.163+0%176.034-8%159.140+2%153.876+6%
Usd Profit--636075300.000687946350.000-8%806359050.000-21%689203830.000-8%657985936.364-3%
Usd Revenue--5608360800.0005467418250.000+3%5779430475.000-3%5205600435.000+8%5099938772.727+10%
Usd Total Gains Per Share--1.9911.837+8%1.104+80%4.153-52%4.153-52%
 EOD+4 -2MRQTTM+22 -12YOY+15 -195Y+16 -1910Y+18 -17

3.3 Fundamental Score

Let's check the fundamental score of Merck & Company Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1524.765
Price to Book Ratio (EOD)Between0-12.101
Net Profit Margin (MRQ)Greater than00.113
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.442
Current Ratio (MRQ)Greater than11.314
Debt to Asset Ratio (MRQ)Less than10.426
Debt to Equity Ratio (MRQ)Less than10.745
Return on Equity (MRQ)Greater than0.150.021
Return on Assets (MRQ)Greater than0.050.012
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Merck & Company Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5021.964
Ma 20Greater thanMa 50148.998
Ma 50Greater thanMa 100155.558
Ma 100Greater thanMa 200159.547
OpenGreater thanClose138.300
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Merck & Company Inc

  • Other
  • 0

There is no Profile data available for MRK.MU.

Fundamental data was last updated by Penke on 2024-11-16 00:21:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Merck & Company Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Merck & Company Inc to the Other industry mean.
  • A Net Profit Margin of 11.3% means that €0.11 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Merck & Company Inc:

  • The MRQ is 11.3%. The company is making a huge profit. +2
  • The TTM is 12.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.3%TTM12.6%-1.3%
TTM12.6%YOY13.9%-1.3%
TTM12.6%5Y13.1%-0.5%
5Y13.1%10Y12.7%+0.4%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ11.3%6.1%+5.2%
TTM12.6%5.9%+6.7%
YOY13.9%5.9%+8.0%
5Y13.1%6.4%+6.7%
10Y12.7%6.3%+6.4%
4.3.1.2. Return on Assets

Shows how efficient Merck & Company Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Merck & Company Inc to the Other industry mean.
  • 1.2% Return on Assets means that Merck & Company Inc generated €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Merck & Company Inc:

  • The MRQ is 1.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.2%TTM1.3%-0.1%
TTM1.3%YOY1.6%-0.2%
TTM1.3%5Y1.4%-0.1%
5Y1.4%10Y1.4%+0.1%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2%1.2%+0.0%
TTM1.3%1.1%+0.2%
YOY1.6%1.5%+0.1%
5Y1.4%1.2%+0.2%
10Y1.4%1.4%0.0%
4.3.1.3. Return on Equity

Shows how efficient Merck & Company Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Merck & Company Inc to the Other industry mean.
  • 2.1% Return on Equity means Merck & Company Inc generated €0.02 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Merck & Company Inc:

  • The MRQ is 2.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.1%TTM2.4%-0.2%
TTM2.4%YOY2.9%-0.5%
TTM2.4%5Y2.9%-0.6%
5Y2.9%10Y2.8%+0.1%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1%3.6%-1.5%
TTM2.4%3.3%-0.9%
YOY2.9%4.1%-1.2%
5Y2.9%3.9%-1.0%
10Y2.8%3.8%-1.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Merck & Company Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Merck & Company Inc is operating .

  • Measures how much profit Merck & Company Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Merck & Company Inc to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Merck & Company Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y8.3%-8.3%
5Y8.3%10Y9.8%-1.6%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.5%-8.5%
TTM-6.6%-6.6%
YOY-7.2%-7.2%
5Y8.3%4.9%+3.4%
10Y9.8%6.8%+3.0%
4.3.2.2. Operating Ratio

Measures how efficient Merck & Company Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 1.25 means that the operating costs are €1.25 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Merck & Company Inc:

  • The MRQ is 1.248. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.260. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.248TTM1.260-0.012
TTM1.260YOY1.188+0.072
TTM1.2605Y1.215+0.046
5Y1.21510Y1.217-0.002
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2481.279-0.031
TTM1.2601.346-0.086
YOY1.1881.330-0.142
5Y1.2151.297-0.082
10Y1.2171.380-0.163
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Merck & Company Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Merck & Company Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 1.31 means the company has €1.31 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Merck & Company Inc:

  • The MRQ is 1.314. The company is just able to pay all its short-term debts.
  • The TTM is 1.398. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.314TTM1.398-0.084
TTM1.398YOY1.371+0.026
TTM1.3985Y1.185+0.213
5Y1.18510Y1.170+0.014
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3141.413-0.099
TTM1.3981.468-0.070
YOY1.3711.568-0.197
5Y1.1851.555-0.370
10Y1.1701.496-0.326
4.4.3.2. Quick Ratio

Measures if Merck & Company Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Merck & Company Inc to the Other industry mean.
  • A Quick Ratio of 0.44 means the company can pay off €0.44 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Merck & Company Inc:

  • The MRQ is 0.442. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.476. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.442TTM0.476-0.034
TTM0.476YOY0.518-0.042
TTM0.4765Y0.425+0.051
5Y0.42510Y0.417+0.008
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4420.542-0.100
TTM0.4760.554-0.078
YOY0.5180.582-0.064
5Y0.4250.590-0.165
10Y0.4170.607-0.190
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Merck & Company Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Merck & Company Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Merck & Company Inc to Other industry mean.
  • A Debt to Asset Ratio of 0.43 means that Merck & Company Inc assets are financed with 42.6% credit (debt) and the remaining percentage (100% - 42.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Merck & Company Inc:

  • The MRQ is 0.426. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.435. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.426TTM0.435-0.009
TTM0.435YOY0.455-0.020
TTM0.4355Y0.511-0.075
5Y0.51110Y0.514-0.004
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4260.526-0.100
TTM0.4350.529-0.094
YOY0.4550.536-0.081
5Y0.5110.553-0.042
10Y0.5140.561-0.047
4.5.4.2. Debt to Equity Ratio

Measures if Merck & Company Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Merck & Company Inc to the Other industry mean.
  • A Debt to Equity ratio of 74.5% means that company has €0.74 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Merck & Company Inc:

  • The MRQ is 0.745. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.773. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.745TTM0.773-0.028
TTM0.773YOY0.837-0.065
TTM0.7735Y1.080-0.307
5Y1.08010Y1.093-0.013
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7451.103-0.358
TTM0.7731.118-0.345
YOY0.8371.180-0.343
5Y1.0801.311-0.231
10Y1.0931.432-0.339
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Merck & Company Inc generates.

  • Above 15 is considered overpriced but always compare Merck & Company Inc to the Other industry mean.
  • A PE ratio of 27.76 means the investor is paying €27.76 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Merck & Company Inc:

  • The EOD is 24.765. Based on the earnings, the company is fair priced.
  • The MRQ is 27.756. Based on the earnings, the company is overpriced. -1
  • The TTM is 25.774. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD24.765MRQ27.756-2.990
MRQ27.756TTM25.774+1.982
TTM25.774YOY24.166+1.607
TTM25.7745Y24.747+1.027
5Y24.74710Y22.497+2.250
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD24.76514.072+10.693
MRQ27.75613.605+14.151
TTM25.77412.015+13.759
YOY24.16610.525+13.641
5Y24.74712.126+12.621
10Y22.49712.658+9.839
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Merck & Company Inc:

  • The EOD is 29.475. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 33.035. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 38.784. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD29.475MRQ33.035-3.559
MRQ33.035TTM38.784-5.750
TTM38.784YOY51.541-12.757
TTM38.7845Y36.816+1.968
5Y36.81610Y33.469+3.347
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD29.4757.895+21.580
MRQ33.0357.759+25.276
TTM38.7846.779+32.005
YOY51.5412.900+48.641
5Y36.8162.726+34.090
10Y33.4694.020+29.449
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Merck & Company Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 2.35 means the investor is paying €2.35 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Merck & Company Inc:

  • The EOD is 2.101. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.355. Based on the equity, the company is underpriced. +1
  • The TTM is 2.408. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.101MRQ2.355-0.254
MRQ2.355TTM2.408-0.053
TTM2.408YOY2.727-0.319
TTM2.4085Y2.811-0.403
5Y2.81110Y2.556+0.256
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD2.1011.563+0.538
MRQ2.3551.395+0.960
TTM2.4081.411+0.997
YOY2.7271.383+1.344
5Y2.8111.642+1.169
10Y2.5561.694+0.862
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Minority Interest  -3,0001,000-2,0000-2,000-3,000-5,0007,0002,000



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets49,875,000
Total Liabilities21,259,000
Total Stockholder Equity28,549,000
 As reported
Total Liabilities 21,259,000
Total Stockholder Equity+ 28,549,000
Total Assets = 49,875,000

Assets

Total Assets49,875,000
Total Current Assets13,047,000
Long-term Assets36,828,000
Total Current Assets
Cash And Cash Equivalents 2,685,000
Short-term Investments 130,000
Net Receivables 4,263,000
Inventory 4,714,000
Other Current Assets 673,000
Total Current Assets  (as reported)13,047,000
Total Current Assets  (calculated)12,465,000
+/- 582,000
Long-term Assets
Property Plant Equipment 9,433,000
Goodwill 18,321,000
Intangible Assets 6,208,000
Long-term Assets Other 133,000
Long-term Assets  (as reported)36,828,000
Long-term Assets  (calculated)34,095,000
+/- 2,733,000

Liabilities & Shareholders' Equity

Total Current Liabilities9,931,000
Long-term Liabilities11,328,000
Total Stockholder Equity28,549,000
Total Current Liabilities
Accounts payable 2,122,000
Other Current Liabilities 1,385,000
Total Current Liabilities  (as reported)9,931,000
Total Current Liabilities  (calculated)3,507,000
+/- 6,424,000
Long-term Liabilities
Long-term Liabilities Other 12,000
Long-term Liabilities  (as reported)11,328,000
Long-term Liabilities  (calculated)12,000
+/- 11,316,000
Total Stockholder Equity
Retained Earnings 21,379,000
Total Stockholder Equity (as reported)28,549,000
Total Stockholder Equity (calculated)21,379,000
+/- 7,170,000
Other
Capital Stock565,000
Common Stock Shares Outstanding 434,778
Net Invested Capital 28,549,000
Net Working Capital 3,116,000



6.3. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
38,717,000
39,568,000
42,067,000
43,811,000
44,743,000
43,822,000
43,231,000
41,796,000
43,891,000
43,145,000
43,836,000
45,362,000
46,235,000
48,717,000
50,933,000
48,535,000
48,637,000
48,782,000
49,906,000
48,495,000
49,504,000
49,875,000
49,875,00049,504,00048,495,00049,906,00048,782,00048,637,00048,535,00050,933,00048,717,00046,235,00045,362,00043,836,00043,145,00043,891,00041,796,00043,231,00043,822,00044,743,00043,811,00042,067,00039,568,00038,717,000
   > Total Current Assets 
10,512,000
11,694,000
13,518,000
9,003,000
10,013,000
9,726,000
10,258,000
9,280,000
10,617,000
10,182,000
10,315,000
10,982,000
11,085,000
12,416,000
12,943,000
12,201,000
12,951,000
13,019,000
13,566,000
12,393,000
12,823,000
13,047,000
13,047,00012,823,00012,393,00013,566,00013,019,00012,951,00012,201,00012,943,00012,416,00011,085,00010,982,00010,315,00010,182,00010,617,0009,280,00010,258,0009,726,00010,013,0009,003,00013,518,00011,694,00010,512,000
       Cash And Cash Equivalents 
2,340,000
3,451,000
5,111,000
541,000
1,530,000
1,512,000
1,548,000
1,110,000
2,238,000
1,825,000
1,523,000
1,511,000
1,339,000
1,580,000
1,604,000
1,398,000
1,584,000
1,761,000
2,365,000
1,578,000
2,220,000
2,685,000
2,685,0002,220,0001,578,0002,365,0001,761,0001,584,0001,398,0001,604,0001,580,0001,339,0001,511,0001,523,0001,825,0002,238,0001,110,0001,548,0001,512,0001,530,000541,0005,111,0003,451,0002,340,000
       Short-term Investments 
64,000
154,000
275,000
29,000
81,000
32,000
85,000
29,000
691,000
45,000
142,000
112,000
106,000
133,000
347,000
244,000
1,653,000
166,000
218,000
431,000
264,000
130,000
130,000264,000431,000218,000166,0001,653,000244,000347,000133,000106,000112,000142,00045,000691,00029,00085,00032,00081,00029,000275,000154,00064,000
       Net Receivables 
3,616,000
3,468,000
3,440,000
3,488,000
3,690,000
3,509,000
3,487,000
3,221,000
3,654,000
3,657,000
3,753,000
3,646,000
4,138,000
4,414,000
4,346,000
4,114,000
4,270,000
4,210,000
4,195,000
4,004,000
4,147,000
4,263,000
4,263,0004,147,0004,004,0004,195,0004,210,0004,270,0004,114,0004,346,0004,414,0004,138,0003,646,0003,753,0003,657,0003,654,0003,221,0003,487,0003,509,0003,690,0003,488,0003,440,0003,468,0003,616,000
       Inventory 
2,937,000
3,033,000
3,135,000
3,342,000
3,443,000
3,537,000
3,428,000
3,294,000
3,462,000
3,564,000
3,760,000
3,900,000
4,143,000
4,474,000
4,860,000
4,632,000
4,890,000
4,996,000
4,971,000
4,637,000
4,716,000
4,714,000
4,714,0004,716,0004,637,0004,971,0004,996,0004,890,0004,632,0004,860,0004,474,0004,143,0003,900,0003,760,0003,564,0003,462,0003,294,0003,428,0003,537,0003,443,0003,342,0003,135,0003,033,0002,937,000
       Other Current Assets 
1,126,000
1,284,000
1,232,000
97,000
553,000
585,000
1,099,000
76,000
0
624,000
683,000
94,000
792,000
1,362,000
1,336,000
151,000
-1,000
1,250,000
1,141,000
127,000
942,000
673,000
673,000942,000127,0001,141,0001,250,000-1,000151,0001,336,0001,362,000792,00094,000683,000624,000076,0001,099,000585,000553,00097,0001,232,0001,284,0001,126,000
   > Long-term Assets 
28,204,000
27,874,000
28,550,000
34,808,000
34,730,000
34,096,000
32,973,000
32,516,000
33,273,000
32,963,000
33,521,000
34,380,000
35,149,000
36,301,000
37,990,000
36,334,000
35,686,000
35,763,000
36,340,000
36,102,000
36,681,000
36,828,000
36,828,00036,681,00036,102,00036,340,00035,763,00035,686,00036,334,00037,990,00036,301,00035,149,00034,380,00033,521,00032,963,00033,273,00032,516,00032,973,00034,096,00034,730,00034,808,00028,550,00027,874,00028,204,000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,946,000
8,204,000
8,218,000
8,393,000
8,719,000
9,056,000
9,214,000
9,433,000
9,433,0009,214,0009,056,0008,719,0008,393,0008,218,0008,204,0007,946,00000000000000000
       Goodwill 
13,966,000
13,841,000
14,309,000
17,141,000
17,376,000
17,118,000
16,512,000
15,959,000
16,541,000
16,347,000
16,670,000
17,004,000
17,761,000
18,573,000
19,534,000
18,389,000
18,077,000
18,102,000
18,466,000
17,845,000
18,181,000
18,321,000
18,321,00018,181,00017,845,00018,466,00018,102,00018,077,00018,389,00019,534,00018,573,00017,761,00017,004,00016,670,00016,347,00016,541,00015,959,00016,512,00017,118,00017,376,00017,141,00014,309,00013,841,00013,966,000
       Intangible Assets 
7,052,000
6,770,000
6,730,000
9,175,000
9,089,000
8,664,000
8,172,000
7,653,000
7,765,000
7,613,000
7,628,000
7,612,000
7,549,000
7,862,000
8,080,000
7,335,000
6,954,000
6,765,000
6,716,000
6,551,000
6,481,000
6,208,000
6,208,0006,481,0006,551,0006,716,0006,765,0006,954,0007,335,0008,080,0007,862,0007,549,0007,612,0007,628,0007,613,0007,765,0007,653,0008,172,0008,664,0009,089,0009,175,0006,730,0006,770,0007,052,000
       Long-term Assets Other 
81,000
87,000
91,000
80,000
94,000
91,000
91,000
62,000
84,000
87,000
84,000
74,000
104,000
99,000
104,000
68,000
99,000
89,000
98,000
76,000
138,000
133,000
133,000138,00076,00098,00089,00099,00068,000104,00099,000104,00074,00084,00087,00084,00062,00091,00091,00094,00080,00091,00087,00081,000
> Total Liabilities 
21,042,000
21,994,000
23,885,000
25,898,000
26,143,000
25,796,000
25,236,000
24,779,000
24,908,000
23,784,000
23,157,000
23,946,000
23,245,000
22,688,000
22,596,000
22,530,000
22,407,000
22,010,000
21,611,000
21,740,000
21,430,000
21,259,000
21,259,00021,430,00021,740,00021,611,00022,010,00022,407,00022,530,00022,596,00022,688,00023,245,00023,946,00023,157,00023,784,00024,908,00024,779,00025,236,00025,796,00026,143,00025,898,00023,885,00021,994,00021,042,000
   > Total Current Liabilities 
11,194,000
10,494,000
9,655,000
11,842,000
10,764,000
10,080,000
9,709,000
9,231,000
10,652,000
9,820,000
9,793,000
10,432,000
10,207,000
9,718,000
9,412,000
9,514,000
9,556,000
8,846,000
8,685,000
8,699,000
9,939,000
9,931,000
9,931,0009,939,0008,699,0008,685,0008,846,0009,556,0009,514,0009,412,0009,718,00010,207,00010,432,0009,793,0009,820,00010,652,0009,231,0009,709,00010,080,00010,764,00011,842,0009,655,00010,494,00011,194,000
       Short-term Debt 
0
0
0
4,423,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000004,423,000000
       Short Long Term Debt 
0
0
0
4,423,000
0
0
0
2,182,000
0
0
0
2,379,000
0
0
0
1,073,000
0
0
0
503,000
0
0
00503,0000001,073,0000002,379,0000002,182,0000004,423,000000
       Accounts payable 
1,633,000
1,737,000
1,736,000
2,054,000
1,807,000
1,764,000
1,684,000
1,768,000
1,937,000
2,107,000
2,132,000
1,542,000
2,356,000
2,456,000
2,445,000
1,596,000
2,326,000
2,403,000
2,244,000
1,770,000
2,086,000
2,122,000
2,122,0002,086,0001,770,0002,244,0002,403,0002,326,0001,596,0002,445,0002,456,0002,356,0001,542,0002,132,0002,107,0001,937,0001,768,0001,684,0001,764,0001,807,0002,054,0001,736,0001,737,0001,633,000
       Other Current Liabilities 
1,863,000
1,629,000
1,688,000
564,000
1,852,000
1,718,000
1,983,000
666,000
2,277,000
2,052,000
2,239,000
839,000
2,417,000
2,297,000
2,474,000
1,000
2,756,000
1,489,000
1,619,000
0
1,607,000
1,385,000
1,385,0001,607,00001,619,0001,489,0002,756,0001,0002,474,0002,297,0002,417,000839,0002,239,0002,052,0002,277,000666,0001,983,0001,718,0001,852,000564,0001,688,0001,629,0001,863,000
   > Long-term Liabilities 
9,848,000
11,500,000
14,230,000
14,056,000
15,379,000
15,716,000
15,527,000
15,548,000
14,256,000
13,964,000
13,364,000
13,514,000
13,038,000
12,970,000
13,184,000
13,016,000
12,851,000
13,164,000
12,926,000
13,041,000
11,491,000
11,328,000
11,328,00011,491,00013,041,00012,926,00013,164,00012,851,00013,016,00013,184,00012,970,00013,038,00013,514,00013,364,00013,964,00014,256,00015,548,00015,527,00015,716,00015,379,00014,056,00014,230,00011,500,0009,848,000
       Capital Lease Obligations Min Short Term Debt
0
0
0
-3,856,000
0
0
0
439,000
0
0
0
459,000
0
0
0
491,000
0
0
0
515,000
0
0
00515,000000491,000000459,000000439,000000-3,856,000000
       Long-term Liabilities Other 
227,000
226,000
225,000
2,000
91,000
88,000
111,000
-1,000
40,000
30,000
15,000
0
15,000
16,000
17,000
2,000
21,000
20,000
18,000
1,000
15,000
12,000
12,00015,0001,00018,00020,00021,0002,00017,00016,00015,000015,00030,00040,000-1,000111,00088,00091,0002,000225,000226,000227,000
> Total Stockholder Equity
17,640,000
17,550,000
18,158,000
17,865,000
18,556,000
17,982,000
17,928,000
16,946,000
18,916,000
19,293,000
20,607,000
21,338,000
22,919,000
25,955,000
28,260,000
25,927,000
26,149,000
26,701,000
28,222,000
26,680,000
27,996,000
28,549,000
28,549,00027,996,00026,680,00028,222,00026,701,00026,149,00025,927,00028,260,00025,955,00022,919,00021,338,00020,607,00019,293,00018,916,00016,946,00017,928,00017,982,00018,556,00017,865,00018,158,00017,550,00017,640,000
   Common Stock0000000000000000000000
   Retained Earnings 
11,294,000
11,410,000
11,314,000
11,507,000
11,978,000
11,753,000
12,581,000
12,378,000
13,511,000
14,134,000
14,955,000
15,134,000
16,450,000
18,015,000
18,825,000
18,463,000
19,250,000
19,760,000
20,711,000
20,228,000
21,031,000
21,379,000
21,379,00021,031,00020,228,00020,711,00019,760,00019,250,00018,463,00018,825,00018,015,00016,450,00015,134,00014,955,00014,134,00013,511,00012,378,00012,581,00011,753,00011,978,00011,507,00011,314,00011,410,00011,294,000
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 0000000000000000000000



6.4. Balance Sheets

Currency in EUR. All numbers in thousands.




6.5. Cash Flows

Currency in EUR. All numbers in thousands.




6.6. Income Statements

Currency in EUR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue20,993,000
Cost of Revenue-8,600,000
Gross Profit12,393,00012,393,000
 
Operating Income (+$)
Gross Profit12,393,000
Operating Expense-17,416,000
Operating Income3,577,000-5,023,000
 
Operating Expense (+$)
Research Development2,445,000
Selling General Administrative5,306,000
Selling And Marketing Expenses0
Operating Expense17,416,0007,751,000
 
Net Interest Income (+$)
Interest Income172,000
Interest Expense-321,000
Other Finance Cost-2,000
Net Interest Income-151,000
 
Pretax Income (+$)
Operating Income3,577,000
Net Interest Income-151,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)3,484,0003,577,000
EBIT - interestExpense = -321,000
2,824,000
3,145,000
Interest Expense321,000
Earnings Before Interest and Taxes (EBIT)03,805,000
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax3,484,000
Tax Provision-650,000
Net Income From Continuing Ops2,834,0002,834,000
Net Income2,824,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0151,000
 

Technical Analysis of Merck & Company Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Merck & Company Inc. The general trend of Merck & Company Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Merck & Company Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Merck & Company Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 139.15 < 143.04 < 143.09.

The bearish price targets are: 133.83.

Tweet this
Merck & Company Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Merck & Company Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Merck & Company Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Merck & Company Inc. The current macd is -4.7976201.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Merck & Company Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Merck & Company Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Merck & Company Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Merck & Company Inc Daily Moving Average Convergence/Divergence (MACD) ChartMerck & Company Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Merck & Company Inc. The current adx is 35.59.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Merck & Company Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Merck & Company Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Merck & Company Inc. The current sar is 152.44.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Merck & Company Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Merck & Company Inc. The current rsi is 21.96. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Merck & Company Inc Daily Relative Strength Index (RSI) ChartMerck & Company Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Merck & Company Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Merck & Company Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Merck & Company Inc Daily Stochastic Oscillator ChartMerck & Company Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Merck & Company Inc. The current cci is -163.32513478.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Merck & Company Inc Daily Commodity Channel Index (CCI) ChartMerck & Company Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Merck & Company Inc. The current cmo is -70.24801678.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Merck & Company Inc Daily Chande Momentum Oscillator (CMO) ChartMerck & Company Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Merck & Company Inc. The current willr is -96.91358025.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Merck & Company Inc Daily Williams %R ChartMerck & Company Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Merck & Company Inc.

Merck & Company Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Merck & Company Inc. The current atr is 1.70140152.

Merck & Company Inc Daily Average True Range (ATR) ChartMerck & Company Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Merck & Company Inc. The current obv is -4,613.

Merck & Company Inc Daily On-Balance Volume (OBV) ChartMerck & Company Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Merck & Company Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Merck & Company Inc Daily Money Flow Index (MFI) ChartMerck & Company Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Merck & Company Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-06MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-09ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Merck & Company Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Merck & Company Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5021.964
Ma 20Greater thanMa 50148.998
Ma 50Greater thanMa 100155.558
Ma 100Greater thanMa 200159.547
OpenGreater thanClose138.300
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Merck & Company Inc with someone you think should read this too:
  • Are you bullish or bearish on Merck & Company Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Merck & Company Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Merck & Company Inc

I send you an email if I find something interesting about Merck & Company Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Merck & Company Inc.

Receive notifications about Merck & Company Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.